Clinical Trial Update: The Treatment Burden of Myopic Choroidal Neovascularization

View source ↗

Summary

A sponsor-led trial evaluating the treatment burden of anti-VEGF therapy for myopic choroidal neovascularization is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopic Choroidal Neovascularization

Snippet

Sponsor: Policlinico Gaspare Rodolico - San Marco Catania | Conditions: Myopic Choroidal Neovascularisation, Anti-VEGF Treatment | Status: NOT_YET_RECRUITING